Check out our past events below.

Access Accelerated and IFPMA hold 2018 UN General Assembly side event


In the days leading up to the third United Nations High-Level Meeting on NCDs, Access Accelerated and IFPMA convened partners and stakeholders at a UN General Assembly side event, “Working Together to Translate Words into Action: NCD Prevention, Treatment and Care.” Held on 25 September at the Harvard Club of New York City, speakers discussed the progress made in one of the initial Access Accelerated focus countries, Kenya, and reaffirmed the commitment to decisive, sustained action on global and local NCD priorities. 

Following opening keynotes from the First Lady of Burkina Faso H.E. Madame Adjoavi Sika Kaboréand Dr. Sania Nishtar, Co-Chair of the WHO High-Level Commission on NCDs, the event’s two panels reflected on the following themes:

  • The need for transformational change in low- and middle-income country health systems to effectively address NCDs.  Panelists spoke about the challenges of integrating NCDs into global and local systems focused primarily on communicable diseases, including the need to break down funding silos and build new capacity at the primary care level. Despite these challenges, opportunities exist to leverage new or existing resources to fight NCDs. For example, in Kenya, the Ministry of Health recently found success in joint tuberculosis / diabetes programming, and a new industry partnership, Ngao ya Afya, is using mobile technology to connect directly with individuals.
From left to right: Justine Hibbert, Roche; H.E. Madame Adjoavi Sika Kaboré, First Lady of Burkina Faso; James Pfitzer, Access Accelerated; and Dr. Eva Njenga, NCD Alliance Kenya.
  • The need to empower people living with NCDs (PLWNCDs) and national governments to co-create sustainable, locally-owned NCD solutions. Civil society was a key participant in the event, with sickle cell advocate Lea Kilenga speaking passionately about keeping PLWNCDs at the center of our efforts, empowering them and understanding their needs holistically as people, not just as patients. Dr. Eva Njenga of NCD Alliance Kenya, reflected on the convening held by Access Accelerated in Nairobi in March and the importance of bringing together NCD advocates, government, the biopharmaceutical industry and other key stakeholders to forge a common path forward.  
From left to right: Dr. Sania Nishtar, Co-Chair of the WHO High-Level Commission on NCDs, and H.E. Madame Adjoavi Sika Kaboré, First Lady of Burkina Faso.
  • The need for greater global mobilisation on NCDs and the catalytic role that Access Accelerated, as a public-private partnership, can play in that process. Progress towards SDG 3.4 has been slow worldwide, and panelists called for greater global and local action, and accountability on NCDs. Notably, Dr. Nishtar highlighted how Access Accelerated serves as catalyst for greater mobilisation, convening critical partners like the World Bank, to make NCDs a priority for investment at the global and local levels. 
From left to right: Dr. Eva Njenga, NCD Alliance Kenya; James Pfitzer, Access Accelerated; Her Royal Highness Princess Dina Mired; Laura Solia Shellaby, UICC; and Shiulie Ghosh, journalist and event moderator.
Notably, two key Access Accelerated partners brought additional contributions to the event, highlighting recent advancements in their work. The PATH Coalition for Access to NCD Medicines and Productsconvened a technical session focused on country-level efforts to reduce fragmentation, strengthen supply chains and institute policies to reduce NCD risk factors. The World Heart Federation also convened a presentation to jointly launch its White Paper on Circulatory Health with Dr. Vytenis Andriukaitis, EU Commissioner for Health, and Dr. Christopher Tufton, Minister of Health of Jamaica.

Overall, as stated by IFPMA representative Martin Bernhardt on the floor of the High-Level Meeting, Access Accelerated and the biopharmaceutical industry stand ready to turn global commitments into practical action and forge innovative public-private partnerships to co-create sustainable solutions to improve people’s health.  We look forward to meeting the challenges laid forth by our partners and stakeholders at this event:
  1. To continue seeking innovative, integrated solutions for NCDs at global and local levels;
  2. To follow through on our commitment to people living with NCDs in Kenya and other LMICs; and
  3. To be a voice for action and mobilisation on NCDs worldwide. 
Following the release of the High-Level Meeting Outcomes Declaration, Access Accelerated will issue a formal report on how we will respond to the needs and concerns of both local stakeholders and the global health community. 

From left to right: The Honorable Dr. Christopher Tufton, Minister of Health, Jamaica; and Greg Perry, IFPMA.
The full list of speakers who contributed to the event’s insightful discussion, include:
  • Her Excellency Madame Adjoavi Sika Kaboré, First Lady of the Republic of Burkina Faso
  • Dr. Sania Nishtar, Co-Chair, WHO High-Level Commission on NCDs
  • Greg Perry, Assistant Director General, IFPMA
  • Dr. Kibachio Joseph Muiruri Mwangi, Ministry of Health for Kenya, Head of the NCD Division
  • Dr. Joseph Lubega, Global Hematology Oncology Pediatric Excellence (HOPE)
  • Dr. Githinji Gitahi, Global CEO, Amref Health Africa
  • Dr. Eva Njenga, Chairperson, NCD Alliance Kenya
  • Lea Kilenga, Sexy Sickle Cell Founder, Advocate and Entrepreneur
  • Dr. Catherine Karekezi, Medical Director, Kenya Diabetes Management and Information Centre
  • Dr. Edward Omete, PharmAccess Foundation, M-TIBA Platform
  • James Pfitzer, Director, Access Accelerated
  • Shiulie Ghosh, journalist and event moderator


World Cancer Congress
1 – 4 October: Kuala Lumpur, Malaysia

The World Cancer Congress aims to strengthen participants’ action and impact on national, regional and international scales through a multidisciplinary programme that features the latest successful interventions in cancer prevention, diagnosis, treatment and care.
On 2 October (17:00 – 18:30, Conference Room Hall 3), Access Accelerated will host a joint event with the City Cancer Challenge program, “Transforming public-private partnerships to strengthen health systems.” The panel will discuss how, through the City Cancer Challenge process, Access Accelerated and C/CAN can take a patient-centered approach to harness the diverse and broad expertise, resources and competencies of local, regional and global partners to support cities to develop their plans and implement sustainable solutions that will save lives.
Follow the conversation using the hashtag, #CityCancerChallenge
The full World Cancer Congress programme can be viewed here; other key panels to attend include:
  • Bridging the Resource Gap: Attracting New Financing to Cancer Care in LMICs: Tuesday, 2 October, 14:20 – 15:20, Conference Room T5-14
  • City Cancer Challenge Partners Briefing on the City Health Financing Lab: Wednesday, 3 October, 12:00 – 13:00, UICC Members’ Convening Room, Global Village
  • Delivering Equitable Access to Quality Cancer Care: Local Champions Driving Change: Thursday, 4 October, 15:00 – 16:30, Conference Room 304


Please contact us at with any questions and follow the conversation around industry actions to tackle NCDs on Twitter at @NCDAccess 


IFPMA (“we”, “us”) owns and operates (“the/our website”). Any person accessing and/or using the website (“the visitor/user”) agrees to the “Terms of Use”, containing the conditions, rules and other provisions with respect to the access and/or use of our website. If you have questions about the “Terms of Use”, please feel free to contact us at


General Use

The material contained on this website is for information only. The website is entitled to be served as an information resource for the internal and external stakeholders of IFPMA, including the general public. Third-Party Websites Links to other websites are provided solely as a convenience and therefore imply neither IFPMA’s responsibility for, nor its approval of the information contained in these websites. Intellectual Property Any use of information from the website should have an acknowledgement of IFPMA/Third-Party as a source respectively, citing the corresponding uniform resource locator (URL). Logo and Name The use of IFPMA’s name and/or logo is prohibited without prior express authorization from IFPMA. The access and/or use of the website does not permit to copy, reproduce, modify, distribute or elsehow exploit IFPMA’s name and/or logo except with the prior explicit permission. Abuse and Violation Any abuse or violations of the Terms of Use and/or Privacy Policy should be reported to


IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.

Privacy Policy

IFPMA is committed to protecting the privacy and security of visitors to our website. Outlined below is our online privacy policy for information collected through our website. If you have questions about these policies, please feel free to contact us at

Personal Information

We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.

Use of Cookies Files

Our website is enhanced by cookie files to personalize and customize the experience of our visitors and to support some necessary functions. IFPMA collects broad usage statistics using Google Analytics, to better understand how our visitors use our website, and to help us improve visitors’ experience. Such information includes the IP address (where available), browser type, and any additional information provided by a browser during the use of our website. The statistical data about our users’ browsing actions and patterns does not identify any individual. You may choose to accept or refuse cookies by modifying your browser preferences. If you wish to get notified when a cookies are set, this option should also be available in your browser settings. Please note that if you reject some or all cookies, your experience at this and other websites throughout the Internet may not be complete.

Payment Transactions

To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.

Third-Party Websites

Please be aware that other websites to which links may be provided, including social media, may collect visitor’s personally identifiable information when accessed. The information collection practices of other websites linked to IFPMA’s website are not covered by this Privacy Policy.

This website uses cookies to ensure you get the best experience on our website. Learn More